APA (7th ed.) Citation

GM, H., CL, B., DEJ, J., AE, K., MJ, M., A, T., . . . C, L. (2026). Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): A randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. The lancet. Gastroenterology & hepatology, 11(1), 22. https://doi.org/10.1016/S2468-1253(25)00192-X

Chicago Style (17th ed.) Citation

GM, Hirschfield, et al. "Linerixibat in Patients with Primary Biliary Cholangitis and Cholestatic Pruritus (GLISTEN): A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase 3 Trial." The Lancet. Gastroenterology & Hepatology 11, no. 1 (2026): 22. https://doi.org/10.1016/S2468-1253(25)00192-X.

MLA (9th ed.) Citation

GM, Hirschfield, et al. "Linerixibat in Patients with Primary Biliary Cholangitis and Cholestatic Pruritus (GLISTEN): A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase 3 Trial." The Lancet. Gastroenterology & Hepatology, vol. 11, no. 1, 2026, p. 22, https://doi.org/10.1016/S2468-1253(25)00192-X.